Clinical epigenetics

Two-way genetic study of links between biological aging and blood clots

Updated

Abstract

A causal association was found between epigenetic age acceleration and deep vein thrombosis of lower extremities (OR 0.963, P = 0.014).

  • Genetically determined levels of plasminogen activator inhibitor-1 are associated with arterial embolism and thrombosis (OR 1.000, P = 0.029).
  • Higher levels of FGF23 are linked to increased risk of other arterial embolism and thrombosis (OR 1.661, P = 0.029).
  • FGF23 is also associated with arterial embolism and thrombosis of lower extremity arteries (OR 1.68, P = 0.037).
  • Bi-directional analysis indicates a reverse effect between portal vein thrombosis and PhenoAge (OR 0.871, P = 0.037).
  • Venous thromboembolism is associated with GrimAge (OR 1.186, P = 0.007).

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declarations. Ethics approval and consent to participate: This study utilized summary statistics from public GWAS studies, for which ethical approvement has been obtained. Consequently, no further ethical approval was necessary. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free